The cannabinoid system and its importance in the perinatal period;El sistema cannabinoide y su importancia en el período perinatal

Anales de Pediatria

Volumn 63, Issue 5, 2005, Pages 433-440

  Martinez Orgado J A ^a   Fernandez Lopez D ^b   Bonet Serra, B ^a   Lizasoain Hernandez I ^b   Romero Paredes, J ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Cannabinoids; Development; Neuroprotection; Newborn

Indexed keywords

AMINO ACID; ARACHIDONIC ACID DERIVATIVE; CANNABINOID; CANNABINOID RECEPTOR; CYTOKINE; LIGAND; NITRIC OXIDE;

ANTINOCICEPTION; BRAIN DEVELOPMENT; BREAST FEEDING; CYTOKINE RELEASE; EMBRYO DEVELOPMENT; FETUS DEVELOPMENT; HORMONE ACTION; IMMUNOMODULATION; MOTOR PERFORMANCE; NEUROPROTECTION; NIDATION; ONTOGENY; OXIDATIVE STRESS; PERINATAL DEVELOPMENT; REVIEW; SYNAPTIC TRANSMISSION; VASODILATATION;

EID: 29844451597     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13080409     Document Type: Article

References (33)

1. Mechoulam R, Lichtman AH. Stout guards of the central nervous system. Science. 2003;302:65-6.
2. Freund TF, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev. 2003;83:1017-66.
3. Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology. 2004;47:345-58.
4. Duran M, Laporte JR, Capellà D. Novedades sobre las potencialidades terapéuticas del Cannabis y el sistema cannabinoide. Med Clin (Barc). 2004;122:390-8.
5. Gaoni Y, Mechoulam R. Isolation, structure and partial síntesis of an active constituent of hashish. J Am Chem Soc. 1964;86:1646-7.
6. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990;346:561-4.
7. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas G, Devane WA, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 2002;54:161-202.
8. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365:61-5.
9. Stella N. Cannabinoid signaling in glial cells. Glia. 2004;48:267-77.
10. Devane WA, Axelrod J. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. Proc Natl Acad Sci U S A. 1994;91:6698-701.
11. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, et al. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun. 1995;215:89-97.
12. Begg M, Pacher P, Batkai S, Osei-Hyiaman D, Offertaler L, Ming Mo F, et al. Evidence for novel cannabinoid receptors. Pharm Ther. 2005;106:133-45.
13. Guzmán M, Sánchez C, Galve-Roperh I. Cannabinoids and cell fate. Pharm Ther. 2002;95:175-84.
14. Klein TW. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nature Rev. 2005;5:400-11.
15. Wilson RI, Nicoll RA. Endocannabinmoid signalling in the brain. Science. 2202;296:678-82.
16. Schuel H, Burkman LJ, Lippes J, Crickard K, Forester E, Piomelli D, et al. N-Acylethanolamines in human reproductive fluids. Chem Phys Lipids. 2002;121:211-27.
17. Paria BC, Wang H, Dey SK. Endocannabinoid signaling in synchronizing embryo development and uterine receptivity for implantation. Chem Phys Lipids. 2002;121:201-10.
18. Maccarrone M, Bisogno T, Valensise H, Lazzarin N, Fezza F, Manna C, et al. Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol Hum Reprod. 2002;8:188-95.
19. Dennedy MC, Friel AM, Houlihan DD, Broderick VM, Smith T, Morrison JJ. Cannabinoids and the human uterus during pregnancy. Am J Obstet Gynecol. 2004;190:2-9.
20. Fride E. The endocannabinoid-CB1 receptor system in pre- and postnatal life. Eur J Pharmacol. 2004;500:289-97.
21. Fride E, Bregman T, Kirkham TC. Endocannabinoids and food intake: Newborn suckling and appetite regulation in adulthood. Exp Biol Med. 2005;230:225-34.
22. Berrendero F, Sepe N, Ramos JA, Di Marzo V, Fernández-Ruiz JJ. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse. 1999;33:181-91.
23. Fernández-Ruiz J, Gómez M, Hernández M, De Miguel R, Ramos JA. Cannabinoids and Gene Expression During Brain Development. Neurotox Res. 2004;6:1-14.
24. Romero J, García-Palomero E, Berrendero F, García-Gil L, Hernández ML, Ramos JA, et al. Atypical location of cannabinoid receptors in white matter areas during rat brain development. Synapse. 1997;26:317-23.
25. Molina-Holgado E, Vela JM, Arévalo-Martín A, Almazán G, Molina-Holgado F, Borrell J, et al. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and Phosphatidylinositol-3 Kinase/Akt signaling. J Neurosci. 2002;22:9742-53.
26. Mechoulam R, Panikashvili D, Shohami E. Cannabinoids and brain injury: therapeutic implications. Trends Mol Med. 2002;8:58-61.
27. Baker D, Pryce G, Giovannoni G, Thompson AJ. The therapeutic potential of cannabis. Lancet Neurology. 2003;2:291-8.
28. Martin Ancel A, Martínez Orgado J. Asfixia perinatal en el recién nacido a término. Pediatría Integral. 2000;5:391-406.
29. Fernández-López D, Martínez-Orgado J, Casanova I, Bonet B, Leza JC, Lorenzo P, et al. Newborn brain slices exposed to oxygen-glucose deprivation as an in vitro model of neonatal hypoxic-ischemic encephalopathy. J Neurosci Meth. 2005;145:205-12.
30. Martínez-Orgado J, Fernández-Frutos B, Gonzalez R, Romero E, Urigüen L, Romero J, et al. Neuroprotection by the cannabinoid agonist WIN-55212 in an in vivo newborn rat model of acute severe asphyxia. Mol Brain Res. 2003;114:132-9.
31. Van der Stelt M, Veldhuis WB, Van Haaften GW, Fezza F, Bisogno T, Bär PR, et al. Exogenous anandamide protects rat brain against acute neuronal injury in vivo. J Neurosci. 2001;21:8765-71.
32. Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, et al. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci. 1999;19:2987-95.
33. Hansen HH, Schmid PC, Bittigau P, Lastres-Becker I, Berrendero F, Manzanares J, et al. Anandamide, but not 2-arachidonylglycerol, accumulates during in vivo neurodegeneration. J Neurochem. 2000;78:1415-27.